A sampling of media coverage that profiles or mentions CCRM
When Trump goes, Canada will need to up its talent game. Toronto Star, December 21, 2020.
Collaboration is key to made-in-Canada healthcare advancements. FedDev Ontario website, Southern Ontario Spotlight, December newsletter, 2020.
Report Finds Growth In Tech Jobs Since February, Canada Still Experiencing Brain Drain. betakit, December 2, 2020.
Harnessing hope through modern medicine. Manufacturing in Focus, December 2020 – January 2021.
Inside Canada’s Premier Life Sciences Mega Hub. Perspective Hamilton, distributed in The Globe and Mail, November 29, 2020.
Biotech campus at McMaster Innovation Park billed as job creator, pandemic fighter. The Hamilton Spectator, November 19, 2020.
CCRM and MIP plan to build a new biomanufacturing campus. Genetic Engineering and Biotechnology News, November 13, 2020.
Toronto accelerator fosters made-in-Canada approach to cell therapy. Canadian Manufacturing, October 23, 2020.
Cell Therapy Scale-Up Strategies For Commercial Success. Biosimilar Development, October 5, 2020.
Canada can become a leader in regenerative medicine. Innovating Canada, September 25, 2020
Robust Process Development For cGMP Manufacturing of Cell Therapies. Cell & Gene, September 24, 2020.
Practical Tips To Develop A Lentivirus Packaging Cell Line. Cell & Gene, September 9, 2020.
Platform Cell and Gene Therapy Media Development. Cell & Gene, September 9, 2020.
Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion. Medicine by Design website, August 13, 2020.
Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system, paper urges. Medicine by Design website, August 13, 2020.
Securing future of regenerative medicine in Victoria [Australia]. The National Tribune, August 10, 2020.
Pluripotent Stem Cell Expansion And Scale-Up. Cell & Gene, August 5, 2020.
Improving Lentiviral Vector Downstream Processing Workflows. Cell & Gene, August 5, 2020.
Notch Therapeutics Appoints David Main as President and CEO to Advance the Company’s Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics. Canadian Life Sciences Database, July 20, 2020.
U of T spin-off Empirica Therapeutics acquired by U.S. firm. U of T News, July 15, 2020.
Innovation Economy Council: Advanced mfg booming in Ontario. Canadian Manufacturing, July 9, 2020.
Professor’s startup acquired by U.S. firm. Brighter World (McMaster University), June 26, 2020.
Medicine by Design Launches Translation Talks. Medicine by Design website, June 16, 2020.
The New Wave of Innovation. Contract Pharma, June 4, 2020.
The Short Report. Research Money, May 20, 2020.
Report: Startups Could Fuel The Recovery Of Canada’s Economy. BetaKit, April 28, 2020.
Tech startups are the foundation of Canada’s economic revival and will need stimulus to survive. The Globe and Mail, April 28, 2020.
Master iPSC bank to be produced by CCRM and panCELLa. RegMedNet, April 23, 2020.
panCELLa, CCRM collaborate to benefit academia and industry. Contract Pharma, April 21, 2020.
Avectas collaborates with CCRM on cell engineering tech. BioPharma Reporter, March 4, 2020.
Advancing Platelet-Based Therapeutics for Patients. Genetic Engineering & Biotechnology News, February 11, 2020
Reflections On An Unprecedented Decade In The Cell And Gene Therapy Field. Cell & Gene, February 4, 2020
Why stem cells could be the medical innovation of the century. World Economic Forum website, January 16, 2020
CCRM helping to solve the big problems in regenerative medicine. Genetic Engineering & Biotechnology News, January 3, 2020